Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma - Concepedia

Concepedia

Publication | Closed Access

Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma

19

Citations

18

References

2016

Year

Surasak Phuphanich, Jeffrey J. Raizer, Marc C. Chamberlain, Paola Canelos, Rajesh Narwal, Shengyan Hong, Robert Miday, Minal Nade, Kevin Laubscher

Journal of Neuro-Oncology

Neuro-oncologyGliomaBlood PlateletMedicineImmunologyPathologyPhase Ii StudyHigh-grade GliomasCancer TreatmentRecurrent GlioblastomaOncologyRadiation OncologyCancer Growth

References

	Year	Citations

Page 1

Page 1